Adverse drug effects and angioedema hospitalizations in the United States from 2000 to 2009

Allergy and Asthma Proceedings

Volumn 34, Issue 1, 2013, Pages 65-71

  Lin, Robert Y ^a,b   Levine, Rozalyn J ^b   Lin, Huei ^c  

^a NEW YORK DOWNTOWN HOSPITAL   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIPYRETIC AGENT; ANTIRHEUMATIC AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AFRICAN AMERICAN; ALCOHOLISM; ALLERGIC URTICARIA; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DRUG HYPERSENSITIVITY; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; INFLUENZA; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; TRACHEOSTOMY; TREND STUDY; UNITED STATES; WESTERN HEMISPHERE;

AFRICAN AMERICANS; ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; FEMALE; HOSPITALIZATION; HUMANS; MALE; TRACHEOSTOMY; UNITED STATES;

EID: 84874312609     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2013.34.3618     Document Type: Article

References (24)

1. Lin RY, and Shah SN. Increasing hospitalizations due to angioedema in the United States. Ann Allergy Asthma Immunol 101:185-192, 2008.
2. Banerji A. Current treatment of hereditary angioedema: An update on clinical studies. Allergy Asthma Proc 31:398-406, 2010.
3. Zilberberg MD, Jacobsen T, and Tillotson G. The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007. Allergy Asthma Proc 31:511-519, 2010.
4. Pigman EC, and Scott JL. Angioedema in the emergency department: The impact of angiotensin-converting enzyme inhibitors. Am J Emerg Med 11:350-354, 1993. (Pubitemid 23227910)
5. Gabb GM, Ryan P, Wing LM, and Hutchinson KA. Epidemiological study of angioedema and ACE inhibitors. Aust N Z J Med 26:777-782, 1996. (Pubitemid 27072782)
6. Byrd JB, Adam A, and Brown NJ. Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am 26:725-737, 2006. (Pubitemid 44679724)
7. Gainer JV, Nadeau JH, Ryder D, and Brown NJ. Increased sensitivity to bradykinin among African Americans. J Allergy Clin Immunol 98:283-287, 1996. (Pubitemid 26326121)
8. HCUP Databases. Healthcare Cost and Utilization Project (HCUP). June 2011. Agency for Healthcare Research and Quality, Rockville, MD. Available online at www.hcup-us.ahrq.gov/ nisoverview.jsp; accessed September 30, 2012.
9. U.S. Census Bureau. Population estimates: Historical data: 2000s. Available online at www.census.gov/popest/data/historical/ 2000s/index.html accessed October 1, 2012.
10. Tai S, Mascaro M, and Goldstein NA. Angioedema: A review of 367 episodes presenting to three tertiary care hospitals. Ann Otol Rhinol Laryngol 119:836-841, 2010.
11. Tseng DS, Kwong J, Rezvani F, and Coates AO. Angiotensinconverting enzyme-related cough among Chinese-Americans. Am J Med 123:183.e11-5, 2010.
12. Gardner W, Mulvey EP, and Shaw EC. Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models. Psychol Bull 118:392-404, 1995.
13. Lin RY, Heacock LC, and Fogel JF. Drug induced, dementia associated, and non-dementia non-drug delirium hospitalizations in the United States: 1998-2005. Drugs Aging 27:51-61, 2010.
14. Ali AK. Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor. Ther Clin Risk Manag 7:337-344, 2011.
15. Jager KJ, Zoccali C, Macleod A, and Dekker FW. Confounding: What it is and how to deal with it. Kidney Int 73:256-260, 2008.
16. Banerji A, Clark S, Blanda M, et al. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 100:327-332, 2008. (Pubitemid 351520323)
17. McNeil DJ, Kinsella TD, Crawford AM, and Fritzler MJ. The AHA syndrome: Arthritis, hives and angioedema. Rheumatol Int 7:277-279, 1987. (Pubitemid 18013945)
18. Zilberberg MD, Nathanson BH, Jacobsen T, and Tillotson G. Descriptive epidemiology of hereditary angioedema hospitalizations in the United States, 2004-2007. Allergy Asthma Proc 32:248-254, 2011.
19. Lin RY, Cannon AG, and Teitel AD. Pattern of hospitalizations for angioedema in New York between 1990 and 2003. Ann Allergy Asthma Immunol 95:159-166, 2005. (Pubitemid 41170177)
20. Roberts DS, Mahoney EJ, Hutchinson CT, et al. Analysis of recurrent angiotensin converting enzyme inhibitor-induced angioedema. Laryngoscope 118:2115-2120, 2008.
21. Makani H, Messerli FH, Romero J, et al. Meta-analysis of randomized trials of angioedema as an adverse event of reninangiotensin system inhibitors. Am J Cardiol 110:383-391, 2012.
22. Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 165: 1637-1642, 2005. (Pubitemid 41124159)
23. Woodard-Grice AV, Lucisano AC, Byrd JB, et al. Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet Genomics 20:532-536, 2010.
24. Schmidt PW, Hirschl MM, and Trautinger F. Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant. J Am Acad Dermatol 63:913-914, 2010.